Hugo M. Horlings - Concepedia

Author

Hugo M. Horlings

Also Known As

Claus K. Høgdall, H Horlings, H M Horlings, H. Horlings, H. M. Horlings, H.M. Horlings, Hernan Garcia-Rivello, Horlings, H.M., Horlings, Hugo, Horlings, Hugo M.

352

Publications

25.3K

Citations

H-Index

Concepts

All Affiliations

The Netherlands Cancer Institute Oncode Institute Amsterdam UMC Location University of Amsterdam University of British Columbia University Medical Center Utrecht

About

Hugo M. Horlings is an author at The Netherlands Cancer Institute specializing in medicine, breast cancer, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	28	39	14.4K
2	Cell Biology	14	14	10.8K
3	Engineering	10	10	7K
4	Health Sciences	2	2	144
5	Biostatistics	2	2	64

Hugo M. Horlings

105

Publications

22.4K

Citations

H-Index

Page 1

	Year	Citations
Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis Rajnish A. Gupta, Nilay Shah, Jeewon Kim, Nature Non-coding Rna HotairChromatinEngineeringChromatin StructureChromatin State	2010	5.2K
AACR Project GENIE: Powering Precision Medicine through an International Consortium Fabrice André, Mónica Arnedos, Alexander S. Baras, Cancer Discovery	2017	1.9K
A Functional Genetic Approach Identifies the PI3K Pathway as a Major Determinant of Trastuzumab Resistance in Breast Cancer Katrien Berns, Hugo M. Horlings, Bryan T. Hennessy, Cancer Cell Systems BiologyBreast OncologyFunctional Genetic ApproachReceptor Tyrosine KinasePi3k Pathway	2007	1.6K
Dysfunctional CD8 T Cells Form a Proliferative, Dynamically Regulated Compartment within Human Melanoma Hanjie Li, Anne M. van der Leun, Ido Yofe, Cell Cancer ImmunosurveillanceHuman MelanomaT-regulatory CellMelanomaImmunology	2018	1.1K
An Integrative Genomic and Proteomic Analysis of PIK3CA, PTEN, and AKT Mutations in Breast Cancer Katherine Stemke‐Hale, Ana M. González-Angulo, Aňa Lluch, Cancer Research Breast OncologyEngineeringIntegrative GenomicPten LossCancer Biology	2008	1K
Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial Leonie Voorwerk, Maarten Slagter, Hugo M. Horlings, Nature Medicine Tumor ImmunologyBreast OncologyCancer ImmunosurveillancePd-1 BlockadeMedicine	2019	854
Recurrent fusion of <i>MYB</i> and <i>NFIB</i> transcription factor genes in carcinomas of the breast and head and neck Marta Persson, Ywonne Andrén, Joachim Mark, Proceedings of the National Academy of Sciences Breast OncologyRecurrent FusionExon 15Cancer BiologyTumor Biology	2009	770
Identification of CMTM6 and CMTM4 as PD-L1 protein regulators Riccardo Mezzadra, Chong Sun, Lucas T. Jae, Nature Protein FunctionSignal TransductionProtein ExpressionMolecular RegulationMolecular Biology	2017	687
Gene expression profiling and histopathological characterization of triple-negative/basal-like breast carcinomas Bas Kreike, Marieke van Kouwenhove, Hugo M. Horlings, Breast Cancer Research	2007	605
Cancer-Associated Mutations in Endometriosis without Cancer Michael S. Anglesio, Nickolas Papadopoulos, A. Ayhan, New England Journal of Medicine	2017	590

Page 1